StockData

Liminatus Pharma, Inc. (LIMN) stock

LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$2.81−0.16 (-5.39%)

Close on Nov 17, 2026Market cap $188.72MP/E –Yield –

Liminatus Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Liminatus Pharma's market cap was $164.56M on Nov 11, 2026, against $1.41B a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$164.56M-80.1%
2025Dec 31, 2025$825.47M–

More Liminatus Pharma figures

See a number that looks wrong?